Improving Health in Developing Countries
We summarize evidence from the growing body of randomized evaluations on health in developing countries from the perspective of the human capital investment model, cost-effectiveness analysis, and behavioral economics. Many cost-effective methods of infectious disease prevention have limited uptake. Contributing factors include externalities from infectious disease prevention, public goods problems, liquidity constraints, and behavioral factors, such as present bias and limited attention. Across a variety of contexts, consumer use of cost-effective products for prevention and non-acute care is highly sensitive to price and convenience. Health education has a mixed record, often working in combination with incentives and functioning through increasing salience rather than delivering information. The quality of health services in many developing countries is very poor, with weak incentives for public sector health workers. Reforms that strengthen incentives show promise but institutional details matter. Programs based on this more nuanced understanding of health decision making can save millions of lives.
|This chapter was published in: ||This item is provided by Elsevier in its series Handbook of Health Economics with number
2-201.||Handle:|| RePEc:eee:heachp:2-201||DOI:|| 10.1016/B978-0-444-53592-4.00004-9||Contact details of provider:|| Web page: http://www.elsevier.com/wps/find/bookseriesdescription.cws_home/BS_HE/description|
When requesting a correction, please mention this item's handle: RePEc:eee:heachp:2-201. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu)
If references are entirely missing, you can add them using this form.